The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Peter Bramlage

Institute for Cardiovascular Pharmacology and Epidemiology

Mahlow

Germany

[email]@ikpe.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Institute for Cardiovascular Pharmacology and Epidemiology, Mahlow, Germany. 2009 - 2010

References

  1. Improving quality of life in hypertension management using a fixed-dose combination of olmesartan and amlodipine in primary care. Bramlage, P., Wolf, W.P., Fronk, E.M., Stuhr, T., Erdlenbruch, W., Wasem, J., Ketelhut, R., Schmieder, R.E. Expert. Opin. Pharmacother (2010) [Pubmed]
  2. Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice. Bramlage, P., Wolf, W.P., Stuhr, T., Fronk, E.M., Erdlenbruch, W., Ketelhut, R., Schmieder, R.E. Vasc. Health. Risk. Manag (2010) [Pubmed]
  3. Differences in pharmacology and their translation into differences in clinical efficacy--a comparison of the renin angiotensin blocking agents irbesartan and losartan. Bramlage, P., Schindler, C. Expert. Opin. Pharmacother (2010) [Pubmed]
  4. A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients. Bramlage, P., Böhm, M., Volpe, M., Khan, B.V., Paar, W.D., Tebbe, U., Thoenes, M. J. Clin. Hypertens. (Greenwich) (2010) [Pubmed]
  5. Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension. Bramlage, P. Vasc. Health. Risk. Manag (2009) [Pubmed]
  6. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension. Bramlage, P. Expert. Opin. Pharmacother (2009) [Pubmed]
 
WikiGenes - Universities